PILL250117P8000
- 0.00
- 0.000.00%
Direxion Daily Pharmaceutical & Medical Bull 3X Sharesのニュース一覧
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
马斯克自曝转用礼来减肥药：效果优于诺和诺德竞品，副作用更少
10 Health Care Stocks With Whale Alerts In Today's Session
Elon Musk Says He Prefers Lilly's Mounjaro Over Novo's Ozempic
Top 7 Blue-Chip Stocks With The Best Return Potential Going Into 2025
Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE
Direxion Daily Pharmaceutical & Medical Bull 3X Shares Declares Quarterly Distribution of $0.0131
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Ely Lilly Shares Are Trading Higher After the FDA Approved the Company's Zepbound, a Weight Loss Drug Designed to Treat Moderate-to-severe Obstructive Sleep Apnea in Adults With Obesity.
Eli Lilly Stock Is Rising Monday: What's Going On?
ResMed, Inspire Medical Fall After Lilly's Zepbound Gains Sleep Apnea Indication
2024's 'Biggest Loses' That Could See Reversal in 2025
Bristol Myers Squibb's Sotyktu Shows Results in Psoriatic Arthritis Trials
Bristol Myers Squibb Wins EU Approval for New Colorectal Cancer Treatment
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Executive Reshuffles: BA, EXPE, TPVG and GEO
Trending Stocks in Bearish Pre-holiday Week for U.S. Stock Market